Ticker ABEO – Abeona Therapeutics – sales, description, marketcap – Tickerday.com

ABEO

Abeona Therapeutics

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 89.02M; Volume: 2.71M; AvgVol 3m: 1.26M; Beta: 1.37;

Cost estimate:

P/E: –; EPS: -1.31; EPS growth quarter/prev quarter: 71.40%;

EPS growth this year: -27.10%; EPS growth past 5 years: 37.00%;

EPS ttm: -1.31;

P/S: ; P/B: 0.94; P/Cashflow: 0.96; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -53.80%; ROE – return on equity: -72.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.01;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.70%; Insider Transactions:-9.99%;

Institutional Ownership: 53.20%; Institutional Transactions: -1.31%;

Data update: 07.10.2020.